Natera, Inc.
Clinical trials sponsored by Natera, Inc., explained in plain language.
-
Blood test may spare stomach cancer patients from unnecessary chemo
Disease control Not yet recruitingThis study looks at whether a personalized blood test (Signatera) can find patients whose cancer is unlikely to return after surgery, allowing them to receive a milder treatment instead of standard chemotherapy. About 1,000 people with stage II-IVa stomach or gastro-esophageal ca…
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
Blood test may spare some women from radiation therapy
Knowledge-focused Not yet recruitingThis study looks at whether a blood test that detects tumor DNA can help decide if women with early-stage endometrial cancer need radiation after surgery. About 1,010 participants will be followed for two years. The goal is to see if those with negative blood tests can safely ski…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 03:15 UTC